| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |